T2 Biosystems (TTOO) EBITDA

Price: $1.82
Market Cap: $31.81M
Avg Volume: 174.70K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 0.313
52W Range: $1.78-33.2
Website: T2 Biosystems

What is T2 Biosystems's EBITDA?

  • T2 Biosystems's annual EBITDA is $-46.29M.
  • T2 Biosystems's quarterly EBITDA is $-9.57M.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess T2 Biosystems's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: -643.60%
    • Quarterly: -490.52%
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: 16.54%
    • Quarterly: 24.01%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: -158.79%
    • Quarterly: 19.76%

These metrics provide insights into T2 Biosystems's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$-46.29M

Quarterly EBITDA

$-9.57M

T2 Biosystems Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)

T2 Biosystems Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2023 $-46.29M 16.54% -643.60% -158.79%
2022 $-55.47M -30.05% -248.69% -63.59%
2021 $-42.66M -3.30% -152.02% 33.25%
2020 $-41.29M 20.06% -227.77% 63.25%
2019 $-51.66M -16.16% -619.77% -46.33%
2018 $-44.47M 12.08% -423.53% 60.93%
2017 $-50.58M 0.25% -1084.03% 12.77%
2016 $-50.71M -17.04% -1242.79% 19.30%
2015 $-43.32M -41.26% -1540.10% 94.02%
2014 $-30.67M -56.29% -25772.27% -249.36%